VJHemOnc is committed to improving our service to you

iwCLL 2019 | Immunoglobulin receptor signalling pathway in CLL

VJHemOnc is committed to improving our service to you

Stefano Casola

Stefano Casola, MD, FIRC Institute of Molecular Oncology, Milan, Italy, elaborates on the role of, and interference with, immunoglobulin receptors in chronic lymphocytic leukemia (CLL), while also discussing the ability to predict resistant tumor cells. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter